Ra pharmaceuticals, inc. (RARX)
Balance Sheet / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Dec'15
Assets
Current assets:
Cash and cash equivalents

264,992

292,602

173,603

191,647

209,822

81,059

95,057

109,122

70,381

84,091

96,605

105,373

117,812

31,196

19,386

Prepaid expenses and other current assets

9,702

7,578

6,051

3,911

2,585

2,502

3,092

1,736

2,496

1,123

1,231

1,632

1,690

669

800

Total current assets

274,694

300,180

179,654

195,558

212,407

83,561

98,149

110,858

72,877

85,214

97,836

107,005

119,502

31,865

20,186

Property and equipment, net

4,732

4,524

4,775

5,015

5,165

5,394

5,709

5,621

5,606

5,967

6,239

6,215

5,537

5,673

2,143

Operating lease right-of-use assets, net

3,100

2,600

2,734

2,864

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

-

183

183

183

183

183

183

183

183

183

183

Intangible assets, net

-

-

-

-

-

147

164

180

197

213

229

246

262

278

327

Restricted cash

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,334

1,463

Other assets

283

300

741

298

314

-

-

-

-

-

-

-

-

1,315

40

Total assets

284,152

308,938

189,238

205,069

219,220

90,619

105,539

118,176

80,197

92,911

105,821

114,983

126,818

40,648

24,342

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

1,817

327

4,498

3,364

3,245

2,899

3,901

2,571

4,348

3,377

3,134

1,715

3,252

2,775

1,319

Accrued expenses

15,178

10,352

6,173

5,322

6,477

4,749

4,092

4,194

3,937

3,994

3,444

3,204

3,182

2,735

1,274

Operating lease liabilities

1,584

987

1,073

1,042

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

479

469

460

450

329

432

422

388

303

219

104

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,621

Preferred stock tranche rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,620

Total current liabilities

18,579

11,666

11,744

9,728

10,201

8,117

8,453

7,215

8,614

7,803

7,000

5,307

6,737

5,729

6,938

Operating lease liabilities, net of current portion

3,438

3,494

3,784

4,066

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, net of current portion

-

-

-

-

1,880

2,003

2,126

2,246

2,359

2,472

2,586

2,696

2,800

2,904

610

Deferred tax liabilities

21

21

21

21

21

40

40

40

40

59

59

59

59

77

77

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

241

Total liabilities

22,038

15,181

15,549

13,815

12,102

10,160

10,619

9,501

11,013

10,334

9,645

8,062

9,596

8,710

7,866

Commitments and contingencies (Note 3 and Note 7)

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding

0

-

-

-

0

0

0

0

-

0

0

0

0

-

0

Common stock, $0.001 par value; 150,000 shares authorized; 47,222 and 42,072 shares issued and outstanding as of December 31, 2019 and 2018, respectively

47

47

42

42

42

32

32

32

23

23

23

23

23

1

1

Additional paid-in capital

552,912

547,778

402,740

398,408

395,233

252,388

250,346

248,355

192,375

190,627

188,951

187,033

185,963

3,330

2,700

Accumulated deficit

-290,800

-254,068

-229,093

-207,196

-188,200

-171,961

-155,458

-139,712

-123,200

-108,073

-92,798

-80,135

-68,764

-57,876

-39,900

Total stockholders' equity

262,114

293,757

173,689

191,254

207,118

80,459

94,920

108,675

69,184

82,577

96,176

106,921

117,222

-54,545

-37,199

Total liabilities and stockholders' equity

284,152

308,938

189,238

205,069

219,220

90,619

105,539

118,176

80,197

92,911

105,821

114,983

126,818

40,648

24,342